LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 23 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,676,380 | +18.2% | 1,560,500 | +56.0% | 0.04% | +13.2% |
| Q2 2023 | $7,340,000 | +38.7% | 1,000,000 | -35.9% | 0.04% | +31.0% |
| Q1 2023 | $5,290,095 | +100.2% | 1,560,500 | +92.5% | 0.03% | +81.2% |
| Q4 2022 | $2,642,230 | -12.4% | 810,500 | 0.0% | 0.02% | -5.9% |
| Q3 2022 | $3,015,000 | +20.4% | 810,500 | 0.0% | 0.02% | +21.4% |
| Q2 2022 | $2,504,000 | -42.1% | 810,500 | 0.0% | 0.01% | -33.3% |
| Q1 2022 | $4,328,000 | +10.3% | 810,500 | 0.0% | 0.02% | +5.0% |
| Q4 2021 | $3,923,000 | -45.3% | 810,500 | 0.0% | 0.02% | -39.4% |
| Q3 2021 | $7,173,000 | -3.0% | 810,500 | 0.0% | 0.03% | +10.0% |
| Q2 2021 | $7,392,000 | -44.3% | 810,500 | 0.0% | 0.03% | -54.5% |
| Q1 2021 | $13,276,000 | – | 810,500 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,273,221 | $12,139,000 | 0.93% |
| Integral Health Asset Management, LLC | 47,600 | $254,000 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 810,500 | $4,328,000 | 0.02% |
| Orbimed Advisors | 113,500 | $606,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $363,000 | 0.01% |
| BAILARD, INC. | 21,200 | $110,000 | 0.00% |
| Alyeska Investment Group, L.P. | 62,500 | $334,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,045,929 | $5,428,000 | 0.00% |
| Veritable, L.P. | 20,534 | $110,000 | 0.00% |
| Laurion Capital Management LP | 20,918 | $109,000 | 0.00% |